Search

Tolka AI Therapeutics (now backed by Khosla Ventures!) is a biotech startup in Miami, Florida focused on developing phage therapy for M. abscessus infections. Tolka is hiring a Microbiology Intern to assist in phage hunting and developing t

Tolka AI Therapeutics (now backed by Khosla Ventures!) is a biotech startup in Miami, Florida focused on developing phage therapy for M. abscessus infections. Tolka is hiring a Microbiology Intern to assist in phage hunting and developing t

In episode 2 of the Podovirus podcast, 'Getting Phage Research Funded', Jessica Sacher interviews Dr. Joe Campbell, who spent the past decade+ as a program officer at NIAID, the US gov's main infectious disease funding body. Dr. Campbell r

Katrine Whiteson (University of California, Irvine) has been awarded a Pilot Program grant for phage therapy research by the Susan Samueli Integrative Health Institute to develop and refine phage therapy protocols for treating antibiotic-re

In episode 2 of the Podovirus podcast, 'Getting Phage Research Funded', Jessica Sacher interviews Dr. Joe Campbell, who spent the past decade+ as a program officer at NIAID, the US gov's main infectious disease funding body. Dr. Campbell r

Armata Pharmaceuticals received a $5.25 million grant from the US Department of Defense for their AP-SA02 'diSArm' clinical trial to treat S. aureus bacteremia.

ePhective (San Francisco) is a newly founded phage therapy company started by Joe Bondy-Denomy from UCSF and Zemer Gitai from Princeton. They are currently looking for: - Two Phage Scientists to lead projects in phage discovery, characteri

Ely O. Aboka of the Phage Hunters Training and Research Program in Nairobi, Kenya will host a LinkedIn Live panel discussion on July 31st, 2024 from 9:00 PM EAT on the topic 'Antimicrobial Resistance (AMR) & Phage Therapy.' Panelists includ

In a new blog post, Alima Yahia (a student at The Knowledge Society starting at Columbia University this Fall) explores phages and why they're needed — including her own challenges with antibiotics. This is a fun, refreshing read; great wor

ePhective (San Francisco) is a newly founded phage therapy company started by Joe Bondy-Denomy from UCSF and Zemer Gitai from Princeton. They are currently looking for: - Two Phage Scientists to lead projects in phage discovery, characteri

Armata Pharmaceuticals has completed enrollment of its Phase 2 Tailwind study, which will evaluate efficacy of inhaled AP-PA02 in non-CF bronchiectasis patients with chronic pulmonary P. aeruginosa infection. Data anticipated in the second

Proteon Pharmaceuticals, JAFRAL, and PTC Phage Technology Center have established a non-profit organization called PhageEU in Brussels. With newly elected members of EU Parliament and European Commission coming into office, PhageEU sees an

In a recent episode of the PhageCast podcast, Graham Hatfull (University of Pittsburgh) discusses the importance of mycobacteriophages and their potential for phage therapy against M. abscessus.

Cytophage Technologies Ltd. have shared the recording of their first investor call since becoming a public company.

PhageEU, a coalition founded by Proteon Pharmaceuticals (Poland), PTC Technology Center (Germany) and JAFRAL (Slovenia) that represents phages in industry, science and civil society, has registered as a non-profit organisation with its seat

We are urgently seeking Enterococcus phages for a patient in the UK. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By helping spread

A recent episode of BBC Sounds' "In Our Time" interviewed Martha Clokie and James Ebdon about how phages can be used to track and cure bacterial illnesses.

Dinesh Subedi (Monash University) and colleagues have developed a five-phage cocktail, Entelli-02 against 156 clinical Enterobacter cloacae complex strains from the Alfred Hospital in Melbourne. They show that Entelli-02 exhibits broad host

Hadil Onallah (Hebrew University of Jerusalem) and colleagues have laid out a step-by-step protocol for compassionate phage therapy outlining phage matching, treatment, and monitoring for non-resolving infections.

The (NIH Division of Microbiology and Infectious Diseases) recently discussed a new suggested funding solicitation for phage therapy centers — here’s the recording of the council meeting!